171 related articles for article (PubMed ID: 26548401)
1. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review).
Long X; Ye Y; Zhang L; Liu P; Yu W; Wei F; Ren X; Yu J
Int J Oncol; 2016 Jan; 48(1):5-12. PubMed ID: 26548401
[TBL] [Abstract][Full Text] [Related]
2. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development.
Dalla Pozza E; Forciniti S; Palmieri M; Dando I
Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.
Xiao D; Barry S; Kmetz D; Egger M; Pan J; Rai SN; Qu J; McMasters KM; Hao H
Cancer Lett; 2016 Jul; 376(2):318-27. PubMed ID: 27063098
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
5. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
6. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.
Fernando RI; Castillo MD; Litzinger M; Hamilton DH; Palena C
Cancer Res; 2011 Aug; 71(15):5296-306. PubMed ID: 21653678
[TBL] [Abstract][Full Text] [Related]
7. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
Dominguez C; David JM; Palena C
Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
[TBL] [Abstract][Full Text] [Related]
9. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
10. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.
Yao D; Dai C; Peng S
Mol Cancer Res; 2011 Dec; 9(12):1608-20. PubMed ID: 21840933
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism involved in epithelial to mesenchymal transition.
Jayachandran J; Srinivasan H; Mani KP
Arch Biochem Biophys; 2021 Oct; 710():108984. PubMed ID: 34252392
[TBL] [Abstract][Full Text] [Related]
13. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
14. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.
Palena C; Hamilton DH; Fernando RI
Future Oncol; 2012 Jun; 8(6):713-22. PubMed ID: 22764769
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway.
Ye Y; Liu P; Wang Y; Li H; Wei F; Cheng Y; Han L; Yu J
Int Rev Immunol; 2016 Jul; 35(4):340-350. PubMed ID: 25215420
[TBL] [Abstract][Full Text] [Related]
18. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation.
Salt MB; Bandyopadhyay S; McCormick F
Cancer Discov; 2014 Feb; 4(2):186-99. PubMed ID: 24302555
[TBL] [Abstract][Full Text] [Related]
20. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
